The AFTD and Target ALS Launch a $5M grant initiative to search for FTD-ALS biomarkers and treatments
October 15, 2019 — Together with the Association for Frontotemporal Degeneration, Target ALS just launched a $5M grant-making initiative to bring scientists together in search of biomarkers and treatment options for FTD and ALS. Call for proposals in link.
October 15, 2019 — Read this profile of a recent publication in Nature Communications from the lab of Dr. Brian Kraemer: Constitutive XBP-1s-Mediated Activation of the Endoplasmic Reticulum Unfolded Protein Response Protects against Pathological Tau.
October 21st: The Garvey Institute for Brain Health Solutions will host speaker Dr. Kristine Yaffe, MD, UCSF
October 08, 2019 — Dr. Kristine Yaffe, MD, Professor of Psychiatry, Neurology, and Epidemiology, UCSF, will present 'Population-Based Strategies for Improving Brain Health.' She will discuss the latest findings and public health implications of modifiable risk factors that could substantially impact brain health, including physical and cognitive activity, and sleep. Monday Oct 21, 2019. 8:00AM. UWMC Health Sciences, Room T739
Call for Pilot Project Applications for the Native Alzheimer’s Disease Resource Center for Minority Aging Research (NAD RCMAR).
October 07, 2019 — The NAD RCMAR program is an 18-month research training program in which investigators will complete both a pilot study and a grant proposal. The pilot studies are aimed to encourage junior investigators and those new to the field to pursue Alzheimer’s and related dementias and health disparities research. Letters of Intent are due by November 15, 2019.
New NIA funding aims to diversify and reinvigorate the Alzheimer’s disease drug development pipeline
October 02, 2019 — On October 1, the National Institute on Aging (NIA) announced that it will infuse $73 million into the Alzheimer's Centers for the Discovery of New Medicines over the next five years, to transform big data into open-access targets and drugs for testing in clinical trials. Sage Bionetworks in Seattle, a member of one of these new centers and UW ADRC collaborator, will help leverage the data and results from the Accelerating Medicines Partnership-Alzheimer's Disease (AMP-AD) program and develop a series of new therapeutic hypotheses centered around a prioritized set of novel targets.
October 28th Toward Precision Medicine Symposium: Dr. Olav Andersen, PhD, Department of Biomedicine-Medicine, Aarhus Univ.
October 01, 2019 — Dr. Olav Andersen, PhD, will present the ADRC's October TPM symposium, titled: the Alzheimer’s disease gene SORL1: Discovery of a novel exon implying synaptic functions besides APP trafficking. October 28th 4-5 PM. Location RR-202 Health Sciences Building
September 20, 2019 — Register for the Huntington's Disease Symposium, held by the UW Medical Center and Oregon Health Sciences University. Key note presentations by Vicki Wheelock, MD of U. Davis & Arik Johnson, PsyD of UCLA! Learn more and register here.
September 17, 2019 — This 2-year $100,000 grant aims to fund the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas, who have the potential to significantly impact our understanding of brain function in normal and diseased states. Application Deadline: Tuesday, October 1, 2019.
Call for Proposals! 2020-2021 UW ADRC Development Projects in Alzheimer’s and Related Dementias Research
August 23, 2019 — The UW Alzheimer’s Disease Research Center is excited to announce the Request for Proposals for the 2020 - 2021 UW ADRC Development Projects, in the form of 3 - 4 projects of up to $50,000 each. The UW ADRC seeks proposals for projects that advance the understanding, diagnosis, and/or treatment of Alzheimer’s disease, FTD, and related dementias.
August 21, 2019 — Junior faculty, post docs, and graduate students are encouraged to attend this event in South Lake Union. Sessions include: Stem cells and Regenerative Capacity in Aging; Genetic and Epigenetics Alterations of Aging; Physiological Heterogeneity and Aging. Find flyer here.